IRON
Disc Medicine Inc.
NASDAQ: IRON · HEALTHCARE · BIOTECHNOLOGY
$70.06
-5.50% today
Updated 2026-09-11
Market cap
$2.94B
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.59
Dividend yield
—
52W range
$40 – $100
Volume
0.4M
WallStSmart proprietary scores
27
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C8.5
Quality
A3.0
Profitability
D5.0
Valuation
C+2/9
Piotroski F-Score
Weak
6.0
Altman Z-Score
Safe zone
—
Industry rank
—
View all highly rated stocks (75+) →251 stocks currently score above 75
Price targets
Analyst target
$102.58
+46.42%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
1 Strong Buy12 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Altman Z 6.02 — safe zone
+ Debt/equity 0.09x — low leverage
Risks
- Piotroski 2/9 — weak financial health
- Thin margins at 0.00%
- Negative free cash flow $-44.20M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-46.09M | $-76.43M | $-109.36M | $-212.18M | $-59.53M |
| EPS | — | — | — | — | $-6.59 |
| Free cash flow | $-42.40M | $-73.55M | $-94.43M | $-181.33M | $-44.20M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Disc Medicine Inc. trades at $70.06. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 2/9 on the Piotroski F-Score. With an Altman Z-Score of 6.02, it sits in the safe zone.
Frequently asked questions
What is Disc Medicine Inc.'s stock price?
Disc Medicine Inc. (IRON) trades at $70.06.
Is Disc Medicine Inc. overvalued?
Disc Medicine Inc. carries a Smart Value Score of 27/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.
What is the price target of Disc Medicine Inc. (IRON)?
The 12-month analyst consensus target is $102.58, about 46.4% above the current $70.06. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
Altman Z-Score?
Disc Medicine Inc.'s Altman Z-Score is 6.02, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-35.09%
Beta2.05
50D MA$77.77
200D MA$74.01
Shares out0.04B
Float0.03B
Short ratio—
Avg volume0.4M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—